{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:52:44Z","timestamp":1788137564808,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 81300379, 91029744, and 81173086"],"award-info":[{"award-number":["Nos. 81300379, 91029744, and 81173086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 81373449"],"award-info":[{"award-number":["Nos. 81373449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Science & Technology Major Project","award":["No. 2012ZX09304-001, 2012ZX09103101-050"],"award-info":[{"award-number":["No. 2012ZX09304-001, 2012ZX09103101-050"]}]},{"name":"the Key Project supported by medical science and technology development Foundation of Nanjing Department of Health","award":["No.ZKX14015"],"award-info":[{"award-number":["No.ZKX14015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00204-015-1552-3","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T13:13:59Z","timestamp":1435065239000},"page":"1507-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells"],"prefix":"10.1007","volume":"90","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"issue":"6","key":"1552_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9(6):400\u2013414. doi: 10.1038\/nrc2657","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1552_CR2","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2007-06-096198","volume":"111","author":"S Baumann","year":"2008","unstructured":"Baumann S, Fas SC, Giaisi M et al (2008) Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+\u00a0-dependent apoptosis. Blood 111(4):2354\u20132363. doi: 10.1182\/blood-2007-06-096198","journal-title":"Blood"},{"issue":"41","key":"1552_CR3","doi-asserted-by":"crossref","first-page":"31087","DOI":"10.1074\/jbc.R110.159079","volume":"285","author":"EH Bresnick","year":"2010","unstructured":"Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S (2010) GATA switches as developmental drivers. J Biol Chem 285(41):31087\u201331093. doi: 10.1074\/jbc.R110.159079","journal-title":"J Biol Chem"},{"issue":"13","key":"1552_CR4","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1093\/nar\/gks281","volume":"40","author":"EH Bresnick","year":"2012","unstructured":"Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS (2012) Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 40(13):5819\u20135831. doi: 10.1093\/nar\/gks281","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1552_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1381612003400948","volume":"6","author":"JK Buolamwini","year":"2000","unstructured":"Buolamwini JK (2000) Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6(4):379\u2013392","journal-title":"Curr Pharm Des"},{"issue":"20","key":"1552_CR6","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1158\/1078-0432.CCR-12-1182","volume":"18","author":"A Cai","year":"2012","unstructured":"Cai A, Keskin DB, DeLuca DS et al (2012) Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients. Clin Cancer Res 18(20):5761\u20135772. doi: 10.1158\/1078-0432.ccr-12-1182","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"1552_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2009.01.010","volume":"259","author":"Y Chen","year":"2009","unstructured":"Chen Y, Lu N, Ling Y et al (2009) Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction. Toxicology 259(1\u20132):10\u201317. doi: 10.1016\/j.tox.2009.01.010","journal-title":"Toxicology"},{"issue":"18","key":"1552_CR8","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood-2012-11-466219","volume":"121","author":"Y Chen","year":"2013","unstructured":"Chen Y, Hui H, Yang H et al (2013) Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells. Blood 121(18):3682\u20133691. doi: 10.1182\/blood-2012-11-466219","journal-title":"Blood"},{"key":"1552_CR9","doi-asserted-by":"crossref","unstructured":"Chou ST, Khandros E, Bailey LC et al (2009) Graded repression of PU.1\/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate. Blood 114(5):983\u2013994. doi:10.1182\/blood-2009-03-207944","DOI":"10.1182\/blood-2009-03-207944"},{"issue":"1","key":"1552_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcdb.2004.11.002","volume":"16","author":"JD Crispino","year":"2005","unstructured":"Crispino JD (2005) GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16(1):137\u2013147. doi: 10.1016\/j.semcdb.2004.11.002","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"1552_CR11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","volume":"5","author":"S Dan","year":"1998","unstructured":"Dan S, Naito M, Tsuruo T (1998) Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR\u2013ABL tyrosine kinase, CGP 57148. Cell Death Differ 5(8):710\u2013715. doi: 10.1038\/sj.cdd.4400400","journal-title":"Cell Death Differ"},{"issue":"4","key":"1552_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4161\/cbt.4.4.1702","volume":"4","author":"ZN Demidenko","year":"2005","unstructured":"Demidenko ZN, An WG, Lee JT, Romanova LY, McCubrey JA, Blagosklonny MV (2005) Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin. Cancer Biol Ther 4(4):484\u2013490","journal-title":"Cancer Biol Ther"},{"issue":"5531","key":"1552_CR13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K et al (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293(5531):876\u2013880. doi: 10.1126\/science.1062538","journal-title":"Science"},{"issue":"15","key":"1552_CR14","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1073\/pnas.1432147100","volume":"100","author":"JA Grass","year":"2003","unstructured":"Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH (2003) GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci USA 100(15):8811\u20138816. doi: 10.1073\/pnas.1432147100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1552_CR15","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1158\/1535-7163.MCT-08-0212","volume":"7","author":"H Gu","year":"2008","unstructured":"Gu H, Wang X, Rao S et al (2008) Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells. Mol Cancer Ther 7(10):3298\u20133305. doi: 10.1158\/1535-7163.mct-08-0212","journal-title":"Mol Cancer Ther"},{"key":"1552_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-4615-4811-9_37","volume":"457","author":"M Hajduch","year":"1999","unstructured":"Hajduch M, Havlieek L, Vesely J, Novotny R, Mihal V, Strnad M (1999) Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Adv Exp Med Biol 457:341\u2013353","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"1552_CR17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1349-7006.2006.00340.x","volume":"97","author":"C Huang","year":"2006","unstructured":"Huang C, Cao J, Huang KJ et al (2006a) Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci 97(12):1417\u20131423. doi: 10.1111\/j.1349-7006.2006.00340.x","journal-title":"Cancer Sci"},{"issue":"50","key":"1552_CR18","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1038\/sj.onc.1209677","volume":"25","author":"Y Huang","year":"2006","unstructured":"Huang Y, Zhao Q, Zhou CX et al (2006b) Antileukemic roles of human phospholipid scramblase 1 gene, evidence from inducible PLSCR1-expressing leukemic cells. Oncogene 25(50):6618\u20136627. doi: 10.1038\/sj.onc.1209677","journal-title":"Oncogene"},{"issue":"5","key":"1552_CR19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.28435","volume":"134","author":"H Hui","year":"2014","unstructured":"Hui H, Chen Y, Yang H et al (2014) Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARgamma and RXRalpha. Int J Cancer 134(5):1195\u20131206. doi: 10.1002\/ijc.28435","journal-title":"Int J Cancer"},{"issue":"6","key":"1552_CR20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0090-4295(00)00467-2","volume":"55","author":"S Ikemoto","year":"2000","unstructured":"Ikemoto S, Sugimura K, Yoshida N et al (2000) Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55(6):951\u2013955","journal-title":"Urology"},{"issue":"5","key":"1552_CR21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","volume":"89","author":"E Jabbour","year":"2014","unstructured":"Jabbour E, Kantarjian H (2014) Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management. Am J Hematol 89(5):547\u2013556. doi: 10.1002\/ajh.23691","journal-title":"Am J Hematol"},{"issue":"5","key":"1552_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J (2010) Ward E (2010) Cancer statistics. CA Cancer J Clin 60(5):277\u2013300. doi: 10.3322\/caac.20073","journal-title":"CA Cancer J Clin"},{"issue":"43","key":"1552_CR23","doi-asserted-by":"crossref","first-page":"15939","DOI":"10.1073\/pnas.0604041103","volume":"103","author":"KD Johnson","year":"2006","unstructured":"Johnson KD, Kim SI, Bresnick EH (2006) Differential sensitivities of transcription factor target genes underlie cell type-specific gene expression profiles. Proc Natl Acad Sci USA 103(43):15939\u201315944. doi: 10.1073\/pnas.0604041103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1552_CR24","doi-asserted-by":"crossref","first-page":"a015412","DOI":"10.1101\/cshperspect.a015412","volume":"3","author":"KR Katsumura","year":"2013","unstructured":"Katsumura KR, DeVilbiss AW, Pope NJ, Johnson KD, Bresnick EH (2013) Transcriptional mechanisms underlying hemoglobin synthesis. Cold Spring Harb Perspect Med 3(9):a015412. doi: 10.1101\/cshperspect.a015412","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"1552_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1073\/pnas.0306315101","volume":"101","author":"DL Letting","year":"2004","unstructured":"Letting DL, Chen YY, Rakowski C, Reedy S, Blobel GA (2004) Context-dependent regulation of GATA-1 by friend of GATA-1. Proc Natl Acad Sci USA 101(2):476\u2013481. doi: 10.1073\/pnas.0306315101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1552_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/bdd.771","volume":"32","author":"C Li","year":"2011","unstructured":"Li C, Lin G, Zuo Z (2011) Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos 32(8):427\u2013445. doi: 10.1002\/bdd.771","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"1552_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-8741(02)00257-X","volume":"84","author":"BO Lim","year":"2003","unstructured":"Lim BO (2003) Effects of wogonin, wogonoside, and 3,5,7,2\u2032,6\u2032-pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat mesenteric lymph node lymphocytes. J Ethnopharmacol 84(1):23\u201329","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1552_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2008.09.005","volume":"35","author":"M Li-Weber","year":"2009","unstructured":"Li-Weber M (2009) New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35(1):57\u201368. doi: 10.1016\/j.ctrv.2008.09.005","journal-title":"Cancer Treat Rev"},{"issue":"26","key":"1552_CR29","doi-asserted-by":"crossref","first-page":"14317","DOI":"10.1073\/pnas.250488697","volume":"97","author":"I Matushansky","year":"2000","unstructured":"Matushansky I, Radparvar F, Skoultchi AI (2000) Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1. Proc Natl Acad Sci USA 97(26):14317\u201314322. doi: 10.1073\/pnas.250488697","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1552_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7(6):441\u2013453. doi: 10.1038\/nrc2147","journal-title":"Nat Rev Cancer"},{"key":"1552_CR31","doi-asserted-by":"crossref","unstructured":"Melo JV, Chuah C (2008) Novel agents in CML therapy: tyrosine kinase inhibitors and beyond. Hematology Am Soc Hematol Educ Prog 427\u2013435. doi: 10.1182\/asheducation-2008.1.427","DOI":"10.1182\/asheducation-2008.1.427"},{"issue":"1","key":"1552_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/2278-330X.105893","volume":"2","author":"H Menon","year":"2013","unstructured":"Menon H (2013) Issues in current management of chronic myeloid leukemia: importance of molecular monitoring on long term outcome. South Asian J Cancer 2(1):38\u201343. doi: 10.4103\/2278-330x.105893","journal-title":"South Asian J Cancer"},{"issue":"3","key":"1552_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20021149","volume":"197","author":"AR Migliaccio","year":"2003","unstructured":"Migliaccio AR, Rana RA, Sanchez M et al (2003) GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 197(3):281\u2013296","journal-title":"J Exp Med"},{"issue":"12","key":"1552_CR34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/mc.20570","volume":"48","author":"R Mu","year":"2009","unstructured":"Mu R, Qi Q, Gu H et al (2009) Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. Mol Carcinog 48(12):1159\u20131169. doi: 10.1002\/mc.20570","journal-title":"Mol Carcinog"},{"issue":"2","key":"1552_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2302\/kjm.60.47","volume":"60","author":"H Nakajima","year":"2011","unstructured":"Nakajima H (2011) Role of transcription factors in differentiation and reprogramming of hematopoietic cells. Keio J Med 60(2):47\u201355","journal-title":"Keio J Med"},{"issue":"10","key":"1552_CR36","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4161\/cc.9.10.11602","volume":"9","author":"M Papetti","year":"2010","unstructured":"Papetti M, Wontakal SN, Stopka T, Skoultchi AI (2010) GATA-1 directly regulates p21 gene expression during erythroid differentiation. Cell Cycle 9(10):1972\u20131980","journal-title":"Cell Cycle"},{"issue":"8","key":"1552_CR37","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Cortes J (2009) Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113(8):1619\u20131630. doi: 10.1182\/blood-2008-03-144790","journal-title":"Blood"},{"issue":"3","key":"1552_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5(3):172\u2013183. doi: 10.1038\/nrc1567","journal-title":"Nat Rev Cancer"},{"issue":"5405","key":"1552_CR39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405):290\u2013293","journal-title":"Nature"},{"issue":"14","key":"1552_CR40","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/MCB.23.14.5031-5042.2003","volume":"23","author":"M Rylski","year":"2003","unstructured":"Rylski M, Welch JJ, Chen YY et al (2003) GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 23(14):5031\u20135042","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1552_CR41","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","volume":"13","author":"CJ Sherr","year":"1999","unstructured":"Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501\u20131512","journal-title":"Genes Dev"},{"issue":"2","key":"1552_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1527-3458.2005.tb00266.x","volume":"11","author":"MC Tai","year":"2005","unstructured":"Tai MC, Tsang SY, Chang LY, Xue H (2005) Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev 11(2):141\u2013150","journal-title":"CNS Drug Rev"},{"issue":"6","key":"1552_CR43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000323973","volume":"26","author":"K Tian","year":"2010","unstructured":"Tian K, Yang S, Ren Q et al (2010) p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell Physiol Biochem 26(6):799\u2013808. doi: 10.1159\/000323973","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"1552_CR44","first-page":"1118","volume":"72","author":"A Tojo","year":"2014","unstructured":"Tojo A (2014) Kinase inhibitors against hematological malignancies. Nihon Rinsho 72(6):1118\u20131124","journal-title":"Nihon Rinsho"},{"issue":"41","key":"1552_CR45","doi-asserted-by":"crossref","first-page":"31774","DOI":"10.1074\/jbc.M110.118653","volume":"285","author":"M Tokunaga","year":"2010","unstructured":"Tokunaga M, Ezoe S, Tanaka H et al (2010) BCR-ABL but not JAK2 V617F inhibits erythropoiesis through the Ras signal by inducing p21CIP1\/WAF1. J Biol Chem 285(41):31774\u201331782. doi: 10.1074\/jbc.M110.118653","journal-title":"J Biol Chem"},{"issue":"1","key":"1552_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)80318-9","volume":"90","author":"AP Tsang","year":"1997","unstructured":"Tsang AP, Visvader JE, Turner CA et al (1997) FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90(1):109\u2013119","journal-title":"Cell"},{"issue":"3","key":"1552_CR47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","volume":"36","author":"K Vermeulen","year":"2003","unstructured":"Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36(3):131\u2013149","journal-title":"Cell Prolif"},{"issue":"7","key":"1552_CR48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.freeradbiomed.2004.01.002","volume":"36","author":"T Walle","year":"2004","unstructured":"Walle T (2004) Absorption and metabolism of flavonoids. Free Radic Biol Med 36(7):829\u2013837. doi: 10.1016\/j.freeradbiomed.2004.01.002","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"1552_CR49","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s10495-013-0854-2","volume":"18","author":"W Wei","year":"2013","unstructured":"Wei W, Huang H, Zhao S et al (2013) Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-kappaB inhibition and Bcr\/Abl protein deletion. Apoptosis 18(9):1060\u20131070. doi: 10.1007\/s10495-013-0854-2","journal-title":"Apoptosis"},{"issue":"11","key":"1552_CR50","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1182\/blood.V95.11.3498","volume":"95","author":"E Weisberg","year":"2000","unstructured":"Weisberg E, Griffin JD (2000) Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR\/ABL-transformed hematopoietic cell lines. Blood 95(11):3498\u20133505","journal-title":"Blood"},{"issue":"18","key":"1552_CR51","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.18632\/oncotarget.2340","volume":"5","author":"H Yang","year":"2014","unstructured":"Yang H, Hui H, Wang Q et al (2014) Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells. Oncotarget 5(18):8188\u20138201","journal-title":"Oncotarget"},{"issue":"11","key":"1552_CR52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.20020656","volume":"195","author":"C Yu","year":"2002","unstructured":"Yu C, Cantor AB, Yang H et al (2002) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 195(11):1387\u20131395","journal-title":"J Exp Med"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-015-1552-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1552-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T17:28:44Z","timestamp":1717954124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-015-1552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s00204-015-1552-3","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}